140 related articles for article (PubMed ID: 8260369)
1. A simulated sequential analysis based on data from two MRC trials.
Donaldson AN; Whitehead J; Stephens R; Machin D
Br J Cancer; 1993 Dec; 68(6):1171-8. PubMed ID: 8260369
[TBL] [Abstract][Full Text] [Related]
2. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Machin D; Stephens RJ
Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
[TBL] [Abstract][Full Text] [Related]
3. Combined modality therapy in small cell lung cancer.
Bunn P; Arriagada R; Choi N; Feld R; Gregor A; Jett J; Johnson B; Komaki R; Kristjansen P; Murray N
Lung Cancer; 1994 Mar; 10 Suppl 1():S25-8. PubMed ID: 8087517
[No Abstract] [Full Text] [Related]
4. [Polychemotherapy and radiotherapy for small cell cancer of the lung].
Linchenko IF; Danil'ian VM
Vopr Onkol; 1983; 29(9):106-14. PubMed ID: 6314659
[No Abstract] [Full Text] [Related]
5. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
Payne DG; Murray N; Warde P
Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
[TBL] [Abstract][Full Text] [Related]
6. [Pilot study of sequential chemotherapy and radiation therapy using of liniac and fast neutron for limited small cell lung cancer].
Takiguchi Y; Nagao K; Miyamoto T; Takamura M; Yasukawa T; Kuriyama T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):957-9. PubMed ID: 7794004
[No Abstract] [Full Text] [Related]
7. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
8. [Multimodality therapy for small-cell lung cancer].
Yokoyama A
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():405-11. PubMed ID: 9369915
[TBL] [Abstract][Full Text] [Related]
9. Triangular test and randomized trials: practical problems in a small cell lung cancer trial.
Pignon JP; Tarayre M; Auquier A; Arriagada R; Le Chevalier T; Ruffié P; Rivière A; Monnet I; Chomy P; Tuchais C
Stat Med; 1994 Jul 15-30; 13(13-14):1415-21. PubMed ID: 7973221
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
11. Results of chemo-radiotherapy and prognostic factors of small cell lung cancer.
Shikaura S; Kawa S; Yoshida M; Yonezu S
Radiat Med; 1991; 9(2):70-6. PubMed ID: 1658856
[TBL] [Abstract][Full Text] [Related]
12. [Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
Navarro M; Mur E; Jolis L; Bellmunt J; Bodi R; Solé LA; Rubio D
Rev Clin Esp; 1991 Oct; 189(5):209-12. PubMed ID: 1666192
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian analysis of institutional effects in a multicenter cancer clinical trial.
Gray RJ
Biometrics; 1994 Mar; 50(1):244-53. PubMed ID: 8086608
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study.
Wampler GL; Heim WJ; Ellison NM; Ahlgren JD; Fryer JG
J Clin Oncol; 1991 Aug; 9(8):1438-45. PubMed ID: 1649265
[TBL] [Abstract][Full Text] [Related]
15. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
16. Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Gregor A; Leonard RC; Machin D; McKenzie CG; Morgan DA; Smyth JF; Spittle MF; Stephens RJ
Br J Cancer; 1994 Jul; 70(1):142-4. PubMed ID: 8018526
[TBL] [Abstract][Full Text] [Related]
17. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung.
Murray N; Shah A; Brown E; Kostashuk E; Laukkanen E; Goldie J; Band P; Van den Hoek J; Murphy K; Sparling T
Semin Oncol; 1986 Sep; 13(3 Suppl 3):24-30. PubMed ID: 3020695
[TBL] [Abstract][Full Text] [Related]
18. [Combination chemotherapy with multimodality approaches for small cell carcinoma of the lung].
Ohnoshi T; Hiraki S; Miyake K; Ozawa S; Kawahara S; Tamura M; Kimura I; Hiraki Y
Gan No Rinsho; 1984 May; 30(6 Suppl):734-40. PubMed ID: 6086974
[TBL] [Abstract][Full Text] [Related]
19. Thoracic radiation therapy in limited stage small-cell lung cancer: timing is everything...isn't it?
Perry MC
J Clin Oncol; 2006 Aug; 24(24):3815-6. PubMed ID: 16921030
[No Abstract] [Full Text] [Related]
20. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Machin D; Stephens RJ
Br J Cancer; 1993 Dec; 68(6):1157-66. PubMed ID: 7505104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
